Table 1.

Demographic data of the study population.

Variables	Total (n = 25)	Survivors (n = 21)	Non-survivors (n = 4)	p-Value
Age (median, IQR)	2.78 [0.21;8.51]	2.13 [0.21;7.3]	10.3 [5.47;13.4]	0.458
Male (%)	15 (60%)	12 (57.1%)	3 (75%)	0.626
Routine vaccination status				1
Fully vaccinated	9 (36%)	8 (38.1%)	1 (25%)
Missed vaccine	7 (28%)	6 (28.6%)	1 (25%)
Unknown	9 (36%)	7 (33.3%)	2 (50%)
Comorbid conditions
Autoimmune disease	2 (8.0%)	2 (9.5%)	0 (0.0%)	1
Chronic lung disease	1 (4.0%)	1 (4.8%)	0 (0.0%)	1
Congenital heart disease	4 (16%)	4 (19.0%)	0 (0.0%)	1
Hematological Malignancy	5 (20%)	4 (19.0%)	1 (25%)	1
Medically complexa	3 (12%)	2 (9.5%)	1 (25%)	0.422
Neurological disease	6 (24%)	4 (19.0%)	2 (50%)	0.234
None	3 (12%)	3 (14.3%)	0 (0.0%)	1
Obesity	2 (8%)	2 (9.5%)	0 (0.0%)	1
Prematurity	4 (16%)	3 (14.3%)	1 (25.0%)	0.527
Sickle cell disease	3 (12%)	3 (14.3%)	0 (0.0%)	1
MRSA colonization	1 (4%)	0 (0.0%)	1 (25%)	0.16
Medical Center:				0.635
1	8 (32%)	6 (28.6%)	2 (50.0%)
2	11 (44%)	10 (47.6%)	1 (25.0%)
3	4 (16%)	3 (14.3%)	1 (25.0%)
4	1 (4%)	1 (4.76%)	0 (0.00%)
5	1 (4%)	1 (4.76%)	0 (0.00%)
Hospital length of stay (median, IQR) (n = 18)	16.5 [9.5;23.5]	17.5 [11.5;23.5]	5.50 [4.25;12.5]	0.121
ICU length of stay (median, IQR) (n = 24)	5 [3.75;21]	4.5 [3.75;21]	5.5 [4.25;11.8]	0.969
Outcomes				< 0.001
Full recovery	18 (72%)	18 (85.7%)	0 (0.0%)
Discharged with sequelae	2 (8%)b	2 (9.5%)	0 (0.0%)
Still Hospitalized	1 (4%)	1 (4.76%)	0 (0.0%)
Death	4 (16%)	0 (0.0%)	4 (100%)

ICU: intensive care unit.

^aDefined as technically dependent children or those diagnosed with genetic or metabolic syndrome.

^bAll required home oxygen therapy.